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Periodontitis, a disease involving supportive structures of the teeth prevails in all
groups, ethnicities, races and both genders. The relationship between bacterial plaque
and the development of periodontal disease and caries is well established (1). Antibacte-
rial agents have been used effectively in the management of periodontal infection. The
effectiveness of mechanical debridement of plaque and repeated topical and systemic
administration of antibacterial agents are limited due to the lack of accessibility to perio-
dontopathic organisms in the periodontal pocket (2). Systemic administration of drugs
leads to therapeutic concentrations at the site of infection, but for short periods of time,
forcing repeated dosing for longer periods (3). Local delivery of antimicrobials has been
investigated for the possibility of overcoming the limitations of conventional therapy.
The use of sustained release formulations to deliver antibacterials to the site of infection
469
Acta Pharm. 57 (2007) 469–477 Original research paper
10.2478/v10007-007-0037-1
Chitosan inserts for periodontitis: Influence of drug loading,










2 Department of Microbiology
Institute of Medical Sciences
Banaras Hindu University
Varanasi-221005, India
3 Faculty of Dental Sciences
Institute of Medical Sciences
Banaras Hindu University
Varanasi-221005, India
Accepted September 10, 2007
Chitosan based metronidazole (MZ) inserts were fabri-
cated by the casting method and characterized with re-
spect to mass and thickness uniformity, metronidazole
loading and in vitro metronidazole release kinetics. The
fabricated inserts exhibited satisfactory physical charac-
teristics. The mass of inserts was in the range of 5.63 ± 0.42
to 6.04 ± 0.89 mg. The thickness ranged from 0.46 ± 0.06
to 0.49 ± 0.08 mm. Metronidazole loading was in the range
of 0.98 ± 0.09 to 1.07 ± 0.07 mg except for batch CM3 with
MZ loading of 2.01 ± 0.08 mg. The inserts exhibited an
initial burst release at the end of 24 h, irrespective of the
drug to polymer ratio, plasticizer content or cross-link-
ing. However, further drug release was sustained over the
next 6 days. Cross-linking with 10% (m/m) of glutaralde-
hyde inhibited the burst release by ~30% and increased
the mean dissolution time (MDT) from 0.67 to 8.59 days.
The decrease in drug release was a result of reduced per-
meability of chitosan due to cross-linking.
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periodontitis, sustained release
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(periodontal pocket) has recently gained interest. These products provide a long-term,
effective treatment at the site of infection at much smaller doses (4). Biodegradable poly-
mers are extensively employed in periodontal drug delivery devices because of their
abundant source, lack of toxicity, and high tissue compatibility (5). Amajor advantage of
natural polymers is that they do not affect periodontal tissue regeneration. Amongst
various natural polymers, chitosan, a deacetylated product of chitin is widely used in
drug delivery devices. Since it exhibits favourable biological properties such as non-tox-
icity, biocompatibility (6), biodegradability and wound healing traits (7), it has attracted
great attention in the pharmaceutical and biomedical fields.
Metronidazole (MZ), a nitroimidazole derivative, is effective against periodontal
pathogens (8–10). It is the drug of choice in the case of pathogenic Gram negative anae-
robes. Systemic metronidazole has been employed in the control of chronic periodontal
diseases (11, 12). Topical metronidazole therapy has been used as an alternative (13) and
as an adjunct to scaling and root planning (14). Dental gels containing metronidazole
(25%, m/V) in glyceryl monooleate have been studied (15–17). The present study is aim-
ed at developing chitosan biodegradable inserts of metronidazole for local long-term
treatment of periodontal disease. The fabricated inserts were evaluated for their physical
properties and in vitro drug release characteristics.
EXPERIMENTAL
Materials
Metronidazole was obtained as a gift sample from M/s Ranbaxy Laboratories (In-
dia). Chitosan (viscosity 0.05 Pa s), was generously donated by Cochin Fisheries Ltd (In-
dia). All other reagents used were of analytical grade.
Methods
Preparation of inserts. – Drug loaded and placebo inserts were prepared by the me-
thod described by Oungbho and Muller (18), with modification. A homogeneous gel-
-like solution of chitosan was prepared by dispersing weighed amount of chitosan in 2%
(V/V) acetic acid under constant stirring. Metronidazole was passed through a 53-µm
sieve and dispersed in 1% (V/V) acetic acid solution. Drug dispersion was mixed with
chitosan solution for 6 h. A measured amount of cross-linking agent (glutaraldehyde/
formaldehyde) was added to the solution and stirred for 6 h. Plasticizer (propylene gly-
col, PG) was then added to the drug-polymer mixture (Table I). After deaerating under
vacuum for 6 h, the drug-polymer mixture was poured on leveled glass moulds at 50 °C
and dried for 10–12 h. The films were subdivided into inserts (2 x 6 mm) by punching
out. Dried films were wrapped in butter paper and stored in amber colored glass vials in
a desiccator until further use.
Physical properties of inserts. – The fabricated inserts were evaluated for thickness,
mass and drug content uniformity (19). Drug content uniformity, between batches and
within batches, was determined by dissolving individually weighed inserts (n = 6) in 5 mL
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of glacial acetic acid in a volumetric flask. After gentle swirling for an hour, the volume
was made up to 100 mL with McIlvaine’s buffer pH 6.6 (potassium dihydrogen ortho-
phosphate and citric acid in water). The final pH of the buffer solution was adjusted us-
ing either 1 mol L–1 potassium dihydrogen orthophosphate solution or 0.5 mol L–1 citric
acid solution, as required. The resultant solution was filtered through a G-2 glass filter
(40 µm). An aliquot of the filtrate was suitably diluted and analyzed for metronidazole
content at 316 nm on a UV spectrophotometer (UV-1601, Shimadzu, Japan). The thick-
ness of the inserts was measured at 5 different randomly selected spots with a screw
gauge. For mass uniformity, 10 inserts from each batch were weighed individually and
their average was determined.
In vitro release studies. – Weighed inserts were placed in a stainless steel wire mesh
(250 µm) holder of dimensions 4 x 8 mm and suspended in amber colored vials containing
10 mL of McIlvaine’s buffer pH 6.6 (to simulate pH of gingival crevicular fluid in vitro)
as the dissolution medium. The vials were stoppered and placed on a vial holder fitted
in a water bath thermostated at 37 ± 1 °C. At pre-determined time intervals, the dissolu-
tion medium was completely withdrawn and replaced with a fresh 10 mL portion of pre-
-warmed buffer, which ensured sink conditions. Since the formulations provide a high ini-
tial burst release of metronidazole, during the first 24 h drug release study, samples were
collected every hour to maintain sink conditions. Metronidazole released was determin-
ed at 316 nm after suitable dilution. A dissolution study of film devoid of metronidazole
was performed concurrently to nullify any interference by film materials.
Drug release kinetics. – The drug release kinetics from the fabricated inserts was eval-
uated using Higuchi’s equation: Q = kt1/2 (20), where Q is the amount of drug released, k
is the release constant and t is time. Further, the data was fitted to Korsmeyer-Peppas’
power law equation: Mt/M¥ = Ktn (21), where, Mt/M¥ is the fraction of drug released in
time t, K is the structural and geometric constant, and n is the release exponent.
Statistical evaluation. – The in vitro data were analyzed for statistical significance us-
ing Student’s t-test.
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Table I. Composition of the fabricated metronidazole inserts by casting method













































PG – propylene glycol
RESULTS AND DISCUSSION
The inserts were prepared by the casting method with controlled solvent evapora-
tion. However, incorporation of plasticizer (propylene glycol) was necessary to obtain
films with sufficient flexibility and allow subsequent sub-division into inserts. The plas-
ticizer concentration was optimized to 40% (V/V). Although a lower level of propylene
glycol could have been used, on drying harder inserts with little or no flexibility were
obtained. The formulated inserts were evaluated for various physico-chemical properties
and the results are given in Table II. The mass and thickness of the prepared inserts was
in the range of 5.63 ± 0.42 to 6.04 ± 0.89 mg and 0.46 ± 0.06 to 0.49 ± 0.08 mm, respectively.
The drug content was found to be in the range of 0.98 ± 0.09 to 1.07 ± 0.07 mg except for
batch CM3 with 2.01 ± 0.08 mg MZ.
Drug release studies were performed by a static method. The inserts released the
drug in a biphasic manner with an initial burst release followed by slow release for the
next 7 days. The lowest burst release of 68% was observed with glutaraldehyde (10%,
m/V) crosslinked inserts batch CM7 (1 mg MZ, PG 40%, m/m). However, further drug
release was sustained for the next 7 days of the release study. The burst effect in the ini-
tial stages could be due to the release of drug entrapped on the surface of inserts. Con-
sidering the initial pathological load in the periodontal pocket, an initial burst release of
anti-microbial is always desirable.
In vitro release studies show that the metronidazole to chitosan ratio plays an im-
portant role in the modulation of metronidazole release from the inserts (Fig. 1). Drug re-
lease decreased as the chitosan ratio in the inserts increased. The release of metronidazole
from batch CM3 (2 mg MZ per insert, PG 10%, m/m) was at a rate of 39 µg h–1 on day 1
in comparison with 33 µg h–1 from batch CM1 (1 mg MZ per insert, PG 10%, m/m). Thus,
nearly 94 and 80% of drug was depleted, respectively, from inserts CM3 and CM1 with
no cross-linking agent, in 24 h. The increased release rate from CM3 might partly due to
the drug entrapped in the superficial layer of the insert. When the insert comes in con-
tact with dissolution medium, the drug from the surface leaches into the surrounding
medium, leaving a more porous polymer structure, which enables faster drug diffusion
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a Mean ± SD, n = 3.
from the matrix. The release rate was found to decrease with increasing the polymer
concentration. As shown in Fig. 2, the concentration of propylene glycol in the inserts
seems to affect the release rate. It was observed that as the concentration of propylene
glycol increased from 10 to 40%, m/m, the rate of metronidazole release increased from
33 µg h–1 in CM1 (10%, m/m, PG) to 38 µg h–1 in CM2 (40%, m/m, PG). The change in the
observed release rate was possibly due to alteration in membrane permeability caused
by the modification of film hydrophilicity by the plasticizer (22).
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Fig. 1. Effect of metronidazo-
le loading on in vitro release
rate from inserts at 24-h time
intervals; inset graph repre-
sents drug release in the first
24 h (Mean ± SD, n = 3).















































Fig. 2. Effect of plasticizer con-
tent on in vitro metronidazole
release at 24-h time intervals;
inset graph represents drug re-
lease in first 24 h (Mean ± SD,
n = 3).
The release rate was affected by the cross-linking of chitosan inserts (Fig. 3). Cross-
-linking of the inserts with either formaldehyde or glutaraldehyde decreased the drug
release rate in comparison with uncross-linked inserts (e.g., CM2, 1 mg MZ, PG 40%, m/m).
However, even after cross-linking, there was no significant decrease in the burst release.
Of the two aldehydes tested, glutaraldehyde as cross-linking agent was more effective in
decreasing both the burst release and subsequent release rate. Chitosan-metronidazole
insert, cross-linked with 10% (m/m) glutaraldehyde (CM7, 1 mg MZ per insert, PG 40%,
m/m) had an initial burst release rate of 29 µg h–1, which gradually decreased to around
1 µg h–1 at the end of 48 h. Further release rate was maintained at 1 µg h–1 to the end of
day 7. The mean dissolution time (MDT) increased to 6.4 and 8.6 days, respectively, for
CM6 and CM7 both containing 1 mg MZ per insert but crosslinked with 5 and 10% (m/m)
glutaraldehyde, respectively. This was a significant change since the not cross-linked insert
(CM2) exhibited MDT of 0.7 days. This difference in release rate is due to the decrease in
the permeability coefficient of the cross-linked membrane resulting from the cross-link
points (23). A similar decrease in meloxicam release from cross-linked gelatin inserts has
been reported recently (24).
Table II shows the treatment of release data according to the Higuchi equation. The
results indicate that the amount of drug released per unit area (Q) increased with the
square root of time. Furthermore, the release coefficient n < 0.45 for all prepared batches,
suggests diffusion as the dominant release mechanism, and not a combination of swel-
ling and erosion. The release rate constant (k) was > 0.7 for all batches. The high release
rate constant was a result of the initial burst release exhibited by the inserts.
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Fig. 3. Effect of cross-linking
with formaldehyde and glu-
taraldehyde on in vitro re-
lease rate of metronidazole in
comparison to uncross-lin-
ked inert; inset graph repre-
sents drug release in first 24 h
(Mean ± SD, n = 3).
CONCLUSIONS
The inserts exhibited burst release, which is desirable considering the initial patho-
genic load in periodontal pockets, but provided sustained release for subsequent six days.
The in vitro evaluation results are encouraging and need further evaluation of the inserts
in patients suffering from periodontitis.
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S A @ E T A K
Kitozanski umetci za periodontitis: Utjecaj koli~ine lijeka, plastifikatora
i umre`avanja na osloba|anje metronidazola in vitro
ROMI BARAT, ANEGUNDHA SRINATHA, JAYANTA K. PANDIT, SHEMPA ANUPURBA i NEELAM MITTAL
Umetci metronidazola na bazi kitozana na~injeni su kasting metodom. Prou~avana
je ujedna~enost mase i debljine, koli~ina ljekovite tvari i kinetika osloba|anja metroni-
dazola in vitro. Fizi~ke karakteristike umetaka bile su zadovoljavaju}e: masa je bila u
rasponu od 5,63 ± 0,42 – 6,04 ± 0,89 mg, debljina od 0.46 ± 0.06 – 0.49 ± 0.08 mm, koli~i-
na metronidazola od 0,98 ± 0,09 – 1,07 ± 0,07 mg osim u pripravku CM3 s MZ 1,07 ± 0,07
mg. Nakon 24 h, neovisno o omjeru ljekovite tvari i polimera, koli~ini plastifikatora ili
umre`avanju, dio metronidazola se naglo oslobodio iz svih umetaka. Me|utim, daljnje
je osloba|anje bilo polagano, tijekom 6 dana. Umre`avanje s 10% (m/m) otopinom glu-
taraldehida sprije~ilo je naglo osloba|anje za ~30% i pove}alo srednje vrijeme osloba|anja
(MDT) s 0,67 na 8,59 dana. Smanjenje u osloba|anju ljekovite tvari posljedica je sma-
njenja permeabilnosti umre`enog kitozana.
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Klju~ne rije~i: kitozanski umetci, umre`avanje, metronidazol, periodontitis, polagano osloba|anje
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